CollPlant

115 articles about CollPlant

• CollPlant Reports Positive Interim Trial Results For VergenixSTR, Indicated For The Treatment Of Tendinopathy

  12/8/2015

• CollPlant Reports Positive Final Trial Results For VergenixFG Wound Filler

  12/1/2015

• CollPlant Announces Completion Of Patient Recruitment For Clinical Trial Of VergenixFG (Flowable Gel) For The Treatment Of Chronic Wounds

  10/7/2015

• CollPlant To Present Results Of Its Product For The Treatment In Tendinopathy, At The 4th TERMIS Congress Which Will Take Place In Boston

  9/8/2015

• CollPlant Names Shomrat Shurtz Senior Director Of Business Development

  7/28/2015

• CollPlant Reports Positive Interim Trial Results For VergenixSTR, For The Treatment Of Tendinopathy

  7/20/2015

• CollPlant Executes Non-Binding Term Sheet To Develop And Commercialize A Novel Product For Spinal Fusion And Trauma Indications In Collaboration With Leading US Partner

  7/13/2015

• CollPlant Reports Positive Interim Trial Results for VergenixFG Wound Healing Gel

  3/19/2015

• CollPlant Appoints Ira Leiderman And Nira Dror To Its Board Of Directors

  3/10/2015

• Another Clinical Trial For CollPlant: Trials For Vergenix®STR Have Begun - A Human Collagen-Based Product For Tendon Repair

  1/12/2015

• CollPlant Launched A Clinical Trial With VergenixFG; A Gel Based On A Human Collagen For The Treatment Of Chronic Wounds

  12/2/2014

• CollPlant Names Dr. Nadav Orr Vice President Research And Development

  9/8/2014

• CollPlant Holds Intellectual Property Rights In USA - One Of The Largest Target Markets For The Company's Products: US Patent Office Approves Patent For Company's Collagen Production Techniques

  6/23/2014

• CollPlant Appoints New CEO

  5/1/2008

• CollPlant Inaugurates its Industrial Greenhouse for the Scale up of Unique, Proprietary Transgenic Tobacco Plant and Production System for Type I Human Collagen

  10/10/2007